Allergy Therapeutics PLC (AIM:AGY, OTC:AGYTF) has scored a major win with marketing approval for Grassmuno in Germany. This is a short, six-injection treatment for pre-season therapy targeting moderate to severe seasonal allergies. Read more
Genflow Biosciences Ltd (LSE:GENF, OTCQB:GENFF) has finished dosing dogs in its gene therapy trial with no adverse events. The company is testing the SIRT6 gene for improvements in longevity and health span. Read more
Oriole Resources PLC (AIM:ORR) has unveiled a preliminary economic assessment for its Bibemi gold project in Cameroon. The study outlines a seven-year mine, producing 10,000 ounces a year, with an after-tax NPV of $12.8 million. Read more
Tertiary Minerals PLC (AIM:TYM, OTC:TTIRF) is starting work to define a JORC-compliant target at its Mushima North silver-copper-zinc prospect. This will give the company a clear range of grades and tonnes to guide future drilling in Zambia. Read more
Active Energy Group PLC (AIM:AEG, OTCQB:ATGVF) plans to use spare digital infrastructure capacity in the UAE for Bitcoin mining. This is a treasury move to generate revenue from idle assets during their staged site energisation. Read more
Follow us and subscribe on YouTube, our social channels and on proactiveinvestors.co.uk.
